Skip to Main Content

Author Details

Joni L Rutter
National Center for Advancing Translational Sciences
1993
66
31
PMIDPaper TitleJournal TitlePublished Year
36730407The NIH-led research response to COVID-19.Science2023
37456265A framework for assessing clinical trial site readiness.J Clin Transl Sci2023
36045637Advancing translational science education.Clin Transl Sci2022
32805036The National COVID Cohort Collaborative (N3C): Rationale, design, infrastructure, and deployment.J Am Med Inform Assoc2021
34674728The IDeaS initiative: pilot study to assess the impact of rare diseases on patients and healthcare systems.Orphanet J Rare Dis2021
34377737Evidence generation and reproducibility in cell and gene therapy research: A call to action.Mol Ther Methods Clin Dev2021
32609747Diversity and inclusion for the All of Us research program: A scoping review.PLoS One2020
31045611Development of the Initial Surveys for the All of Us Research Program.Epidemiology2019
31412182The "All of Us" Research Program.N Engl J Med2019
30114233Correction: A collaborative translational research framework for evaluating and implementing the appropriate use of human genome sequencing to improve health.PLoS Med2018
30071015A collaborative translational research framework for evaluating and implementing the appropriate use of human genome sequencing to improve health.PLoS Med2018
25421653Community resources and technologies developed through the NIH Roadmap Epigenomics Program.Methods Mol Biol2015
25722961Neuroepigenomics: Resources, Obstacles, and Opportunities.Neuroepigenetics2015
24529194Emerging trends in the abuse of designer drugs and their catastrophic health effects: update on chemistry, pharmacology, toxicology and addiction potential.Life Sci2014
25077169Re-defininG AddiC(CH3)Tion: genomics and epigenomics on substance use disorders.Mol Genet Genomic Med2014
25015040Cannabinoid receptor-2 and HIV-associated neurocognitive disorders.J Neuroimmune Pharmacol2014
25162809Data use under the NIH GWAS data sharing policy and future directions.Nat Genet2014
23456951National Institute on Drug Abuse symposium report: drugs of abuse, dopamine, and HIV-associated neurocognitive disorders/HIV-associated dementia.J Neurovirol2013
22527633Do opioids activate latent HIV-1 by down-regulating anti-HIV microRNAs?J Neuroimmune Pharmacol2012
21308768Gene-environment interplay in common complex diseases: forging an integrative modelâ¿¿recommendations from an NIH workshop.Genet Epidemiol2011
20462706Measuring addiction propensity and severity: the need for a new instrument.Drug Alcohol Depend2010
19138047Thyroid nodules, polymorphic variants in DNA repair and RET-related genes, and interaction with ionizing radiation exposure from nuclear tests in Kazakhstan.Radiat Res2009
19381300Supplementing high-density SNP microarrays for additional coverage of disease-related genes: addiction as a paradigm.PLoS One2009
18158280Similar prevalence of founder BRCA1 and BRCA2 mutations among Ashkenazi and non-Ashkenazi men with breast cancer: evidence from 261 cases in Israel, 1976-1999.Eur J Med Genet2008
18936755One SNP linked to two diseases-addiction and cancer: a double whammy? Nicotine addiction and lung cancer susceptibility.Mol Psychiatry2008
18395495An ontology-driven semantic mashup of gene and biological pathway information: application to the domain of nicotine dependence.J Biomed Inform2008
17158188Novel genes identified in a high-density genome wide association study for nicotine dependence.Hum Mol Genet2007
17977095The nuts and bolts of gene array technology and its application to drug abuse research.Drug Alcohol Depend2007
17327520Genetic research and smoking behavior.JAMA2007
17135278Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs.Hum Mol Genet2007
16584126Symbiotic relationship of pharmacogenetics and drugs of abuse.AAPS J2006
17045619Identification and characterization of novel human transcripts embedded within HMGA2 in t(12;14)(q15;q24.1) uterine leiomyoma.Mutat Res2006
16923772Candidate single nucleotide polymorphism selection using publicly available tools: a guide for epidemiologists.Am J Epidemiol2006
15113441Kin-cohort estimates for familial breast cancer risk in relation to variants in DNA base excision repair, BRCA1 interacting and growth factor genes.BMC Cancer2004
15529312Heterogeneity of risk for melanoma and pancreatic and digestive malignancies: a melanoma case-control study.Cancer2004
15178784Setting priorities for genomic research.Science2004
12538496Elevated sod2 activity augments matrix metalloproteinase expression: evidence for the involvement of endogenous hydrogen peroxide in regulating metastasis.Clin Cancer Res2003
12928354Re: Population-based, case-control study of HER2 genetic polymorphism and breast cancer risk.J Natl Cancer Inst2003
12872252Mutational analysis of the BRCA1-interacting genes ZNF350/ZBRK1 and BRIP1/BACH1 among BRCA1 and BRCA2-negative probands from breast-ovarian cancer families and among early-onset breast cancer cases and reference individuals.Hum Mutat2003
14569185The HER2 I655V polymorphism and breast cancer risk in Ashkenazim.Epidemiology2003
14569130A twofold increase in BRCA mutation related prostate cancer among Ashkenazi Israelis is not associated with distinctive histopathology.J Med Genet2003
12853981CDKN2A point mutations D153spl(c.457G>T) and IVS2+1G>T result in aberrant splice products affecting both p16INK4a and p14ARF.Oncogene2003
12865453Gynecologic surgeries and risk of ovarian cancer in women with BRCA1 and BRCA2 Ashkenazi founder mutations: an Israeli population-based case-control study.J Natl Cancer Inst2003
11754476Efficiency of DNA pooling to estimate joint allele frequencies and measure linkage disequilibrium.Genet Epidemiol2002
12407683Two approaches to mutation detection based on functional data.Stat Med2002
11159206Loss of heterozygosity on chromosome 11q22-23 in melanoma is associated with retention of the insertion polymorphism in the matrix metalloproteinase-1 promoter.Am J Pathol2001
11297530Manganese superoxide dismutase signals matrix metalloproteinase expression via H2O2-dependent ERK1/2 activation.J Biol Chem2001
11665970Synergistic induction of matrix metalloproteinase 1 by interleukin-1alpha and oncostatin M in human chondrocytes involves signal transducer and activator of transcription and activator protein 1 transcription factors via a novel mechanism.Arthritis Rheum2001
11401920Collection of genomic DNA from adults in epidemiological studies by buccal cytobrush and mouthwash.Cancer Epidemiol Biomarkers Prev2001
11156241Interstitial collagenases as markers of tumor progression.Clin Cancer Res2000
  • 1 - 50 of 66

Recommended Authors

University of Dhaka
Career Start Year 2004
Number of shared co-authors 0
Geisel School of Medicine at Dartmouth
Career Start Year 2004
Number of shared co-authors 2
Marshfield Clinic Research Institute
Career Start Year 2003
Number of shared co-authors 11
Fox Chase Cancer Center
Career Start Year 2002
Number of shared co-authors 0
University of Goettingen
Career Start Year 2001
Number of shared co-authors 9
Mayo Clinic
Career Start Year 2001
Number of shared co-authors 2
The Scripps Research Institute
Career Start Year 1999
Number of shared co-authors 2
Mayo Clinic
Career Start Year 1999
Number of shared co-authors 3
National Cancer Institute, National Institutes of Health
Career Start Year 1999
Number of shared co-authors 11
HudsonAlpha Institute for Biotechnology
Career Start Year 1999
Number of shared co-authors 11
University of Texas Southwestern Medical Center
Career Start Year 1999
Number of shared co-authors 2
Arkansas Children's Research Institute
Career Start Year 1998
Number of shared co-authors 6
William Harvey Research Institute, Queen Mary University of London
Career Start Year 1997
Number of shared co-authors 12
National Human Genome Research Institute, National Institutes of Health
Career Start Year 1995
Number of shared co-authors 10
Frederick National Laboratory for Cancer Research
Career Start Year 1993
Number of shared co-authors 16
Center for Cancer Equity and Engagement, Dana-Farber/Harvard Cancer Center
Career Start Year 1991
Number of shared co-authors 12
Stanford University School of Medicine
Career Start Year 1991
Number of shared co-authors 4
Ontario Institute for Cancer Research
Career Start Year 1991
Number of shared co-authors 16
Dartmouth Health and the Dartmouth Cancer Center, USA Geisel School of Medicine
Career Start Year 1990
Number of shared co-authors 2
Genomic Medicine Institute, Medical Research Center, Seoul National University
Career Start Year 1989
Number of shared co-authors 1
Center for Bioinformatics, University of Oslo
Career Start Year 1987
Number of shared co-authors 0
University of Toronto
Career Start Year 1987
Number of shared co-authors 7
Baylor College of Medicine
Career Start Year 1986
Number of shared co-authors 24
National Cancer Institute, National Institutes of Health
Career Start Year 1983
Number of shared co-authors 38
Mayo Clinic
Career Start Year 1982
Number of shared co-authors 20
Mayo Clinic
Career Start Year 1979
Number of shared co-authors 14
University of Oxford
Career Start Year 1978
Number of shared co-authors 5
University of Washington
Career Start Year 1975
Number of shared co-authors 6
Johns Hopkins School of Medicine, National Cancer Institute, Princeton University, University of Colorado Anschutz Medical Campus, University of Pittsburgh, University of Washington
Career Start Year 1974
Number of shared co-authors 14
and School of Public Health, University of Michigan ann arbor
Career Start Year 1965
Number of shared co-authors 7

Collaborators

National Human Genome Research Institute, National Institutes of Health
Co-authored papers 12
Co-authored papers 6
National Cancer Institute
Co-authored papers 4
Washington University School of Medicine
Co-authored papers 3
Co-authored papers 3
Co-authored papers 3
Vanderbilt University
Co-authored papers 3
Co-authored papers 3
Patient-Centered Outcomes Research Institute
Co-authored papers 3
American Medical Informatics Association, Oregon Health and Science University, Oregon State University, University of Colorado Anschutz Medical Campus, University of North Carolina at Chapel Hill, University of Wisconsin-Madison
Co-authored papers 2
Co-authored papers 2
Center for Cancer Research, National Cancer Institute
Co-authored papers 2
Centers for Disease Control and Prevention Atlanta GA USA.
Co-authored papers 2
Co-authored papers 2
Brigham and Women's Hospital, Broad Institute Ariadne Labs and Harvard Medical School
Co-authored papers 2
St. George's University Medical School
Co-authored papers 2
Memorial Sloan-Kettering Cancer Center
Co-authored papers 2
Co-authored papers 2
Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University
Co-authored papers 2
Icahn School of Medicine at Mount Sinai
Co-authored papers 2
Co-authored papers 2
National Cancer Institute
Co-authored papers 2
Co-authored papers 2
National Center for Biotechnology Information, National Institutes of Health
Co-authored papers 2
Yale School of Medicine
Co-authored papers 2
Co-authored papers 2
Present address: Inscripta Inc.
Co-authored papers 2
University of Massachusetts Medical School
Co-authored papers 2
National Cancer Institute, National Institutes of Health
Co-authored papers 2
National Institutes of Health
Co-authored papers 2